Related Experiment Video
Updated: Aug 23, 2025

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Nontuberculous mycobacteria infections of the pleura: A systematic review
Keren Bachar1, Tiberiu Shulimzon2, Michael J Segel3
1Institute of Pulmonology, Sheba Tel-HaShomer Medical Center, Ramat Gan, Israel; Medical Corps, Israel Defense Forces, Israel.
Background:
Nontuberculous mycobacterial (NTM) pleuritis is an uncommon manifestation of NTM infection. Case reports and small case series have shown a variable clinical course and high mortality rates.
Objective:
To describe patients' characteristics, clinical presentation and outcomes of NTM pleural infections.
Methods:
A systematic review of cases of NTM pleural infections published in PubMed-indexed journals from 1980 to 2021.
Results:
A total of 206 cases of NTM pleural infections were found and analyzed. Fifty-eight percent of cases were males. The mean age was 57.5 yrs (range 9-87 yrs). Forty-three percent of patients were immunosuppressed, and 43% had a chronic lung disease; thirty-two percent had neither risk factor. In addition to the pleural infection, 67% of cases had a concurrent pulmonary NTM infection, and in 18 cases there was another extrapulmonary site of NTM infection. In 29% of cases the pleural infection was the sole manifestation of NTM disease. The most common isolated mycobacterium was Mycobacterium avium complex (65%). Fifty-three percent and 26% of patients required pleural effusion drainage and a surgical intervention, respectively, to treat the infection, in addition to anti-NTM chemotherapy. Forty percent of patients developed pneumothorax, 16% suffered from empyema, and 16.5% had broncho-pleural fistula. The reported mortality rate was 24%.
Conclusion:
NTM pleural infections may arise in immunocompetent and immunosuppressed patients, with or without chronic lung disease or concurrent NTM pulmonary infection. These infections carry a poor prognosis and a high risk of complications requiring surgical interventions in addition to anti-NTM chemotherapy.
Insights
Nontuberculous mycobacterial (NTM) pleuritis is rare but serious, affecting diverse patients and often requiring surgery. These NTM pleural infections have a high mortality rate of 24% and significant complications.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Nontuberculous mycobacterial (NTM) pleuritis is an uncommon yet severe manifestation of NTM infection.
- Existing literature consists primarily of case reports and small series, indicating a variable clinical course and high mortality rates.
Approach:
- A systematic review was conducted, analyzing 206 cases of NTM pleural infections published in PubMed-indexed journals between 1980 and 2021.
- Data on patient demographics, clinical presentation, microbiological findings, treatment interventions, complications, and outcomes were extracted and analyzed.
Key Points:
- NTM pleural infections occurred in both immunocompetent and immunosuppressed individuals, with or without chronic lung disease or concurrent pulmonary NTM infection.
- Mycobacterium avium complex was the most common pathogen (65%).
- High complication rates included pneumothorax (40%), empyema (16%), and broncho-pleural fistula (16.5%), with a 24% mortality rate.
Conclusions:
- NTM pleural infections present a significant clinical challenge with a poor prognosis.
- Effective management often necessitates a combination of anti-NTM chemotherapy, pleural effusion drainage, and surgical interventions.
- The high incidence of complications underscores the need for prompt diagnosis and aggressive treatment strategies.
More Related Videos
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumothorax-II
Clinical Manifestations:
Pneumonia III: Complications and Assessment
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: